Search research articles
Contact Us
Filters
Showing results (71-80 of 121) with videos related to
Page
of 13
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1992
Recombinant tumor necrosis factor for superficial bladder tumors
C N Sternberg, M G Arena, V Pansadoro, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 1, 1995
Neoadjuvant and adjuvant chemotherapy in advanced disease--what are the effects on survival and prognosis?
C N Sternberg, D Raghaven, Y Ohi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2014
Improved outcomes in elderly patients with metastatic castration-resistant prostate cancer treated with the androgen receptor inhibitor enzalutamide: results from the phase III AFFIRM trial
C N Sternberg, J S de Bono, K N Chi, et al.
Cancer
|
December 15, 1991
Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors
A D Seidman, H I Scher, M H Heinemann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 22, 2011
Health-related quality of life in patients with advanced renal cell carcinoma receiving pazopanib or placebo in a randomised phase III trial
D Cella, A S Pickard, M S Duh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 20, 2009
Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer
C N Sternberg, H Dumez, H Van Poppel, et al.
ESMO Open
|
November 17, 2023
Avelumab first-line maintenance treatment for advanced urothelial carcinoma: review of evidence to guide clinical practice
P Grivas, E Grande, I D Davis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 17, 2009
Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study
L Celio, C N Sternberg, R Labianca, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1986
Phase I/II trial of intravesical methotrexate for superficial bladder tumors
C N Sternberg, A Yagoda, N H Bander, et al.
The Journal of Urology
|
March 1, 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion
H I Scher, A Yagoda, H W Herr, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 121) with videos related to
Sort By:
Page
of 13
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1992
Recombinant tumor necrosis factor for superficial bladder tumors
C N Sternberg, M G Arena, V Pansadoro, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 1, 1995
Neoadjuvant and adjuvant chemotherapy in advanced disease--what are the effects on survival and prognosis?
C N Sternberg, D Raghaven, Y Ohi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 31, 2014
Improved outcomes in elderly patients with metastatic castration-resistant prostate cancer treated with the androgen receptor inhibitor enzalutamide: results from the phase III AFFIRM trial
C N Sternberg, J S de Bono, K N Chi, et al.
Cancer
|
December 15, 1991
Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors
A D Seidman, H I Scher, M H Heinemann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 22, 2011
Health-related quality of life in patients with advanced renal cell carcinoma receiving pazopanib or placebo in a randomised phase III trial
D Cella, A S Pickard, M S Duh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 20, 2009
Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer
C N Sternberg, H Dumez, H Van Poppel, et al.
ESMO Open
|
November 17, 2023
Avelumab first-line maintenance treatment for advanced urothelial carcinoma: review of evidence to guide clinical practice
P Grivas, E Grande, I D Davis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 17, 2009
Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study
L Celio, C N Sternberg, R Labianca, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1986
Phase I/II trial of intravesical methotrexate for superficial bladder tumors
C N Sternberg, A Yagoda, N H Bander, et al.
The Journal of Urology
|
March 1, 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion
H I Scher, A Yagoda, H W Herr, et al.
Page
of 13